Skip to main content

Qube Research & Technologies Ltd

Source: SEC Form 13F · as of Mar 2026

Qube Research & Technologies Ltd holds 136 biotech & pharma companies tracked by BioSniper, totaling $1.76B in value as of Mar 2026 (SEC Form 13F).

Companies held

136

Total value held

$1.76B

BioSniper AIPage evidence connected

Prepared research question

What matters most for ALNYLAM PHARMACEUTICALS, INC. (ALNY)—catalysts, financial risk and supporting evidence?

Run cited research

Traceable citations · Unknowns marked

CompanySharesValue
ALNYALNYLAM PHARMACEUTICALS, INC.838,187$277.3M
FOLDAMICUS THERAPEUTICS, INC.8,809,340$127.4M
ROIVRoivant Sciences Ltd.3,450,904$95.6M
REGNREGENERON PHARMACEUTICALS, INC.83,358$64.4M
AXSMAxsome Therapeutics, Inc.335,334$56.7M
RVMDREVOLUTION MEDICINES, INC.553,290$53.8M
CYTKCYTOKINETICS INC779,446$51.4M
JAZZJazz Pharmaceuticals plc262,553$49.6M
DAWNDay One Biopharmaceuticals, Inc.1,954,552$41.9M
BMRNBIOMARIN PHARMACEUTICAL INC689,721$39.0M
MRNAModerna, Inc.700,692$35.6M
PTCTPTC THERAPEUTICS, INC.513,823$35.0M
KNSAKiniksa Pharmaceuticals International, plc686,853$33.1M
GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares)548,222$30.3M
TERNTerns Pharmaceuticals, Inc.537,884$28.4M
NKTRNEKTAR THERAPEUTICS390,675$28.1M
BEAMBeam Therapeutics Inc.1,084,768$25.9M
SUPNSUPERNUS PHARMACEUTICALS, INC.498,198$25.8M
CNTACentessa Pharmaceuticals plc628,049$24.9M
INSMINSMED Inc148,515$24.3M
RYTMRHYTHM PHARMACEUTICALS, INC.277,943$24.2M
XERSXeris Biopharma Holdings, Inc.4,114,425$23.9M
ACADACADIA PHARMACEUTICALS INC950,299$21.2M
TVTXTravere Therapeutics, Inc.669,159$19.9M
ARGXARGENX SE25,536$18.6M
INVAInnoviva, Inc.786,107$18.3M
GMABGenmab A/S677,346$18.2M
ANNXAnnexon, Inc.3,114,314$17.3M
ARQTArcutis Biotherapeutics, Inc.724,067$17.1M
GILDGILEAD SCIENCES, INC.121,052$16.9M
ADMAADMA BIOLOGICS, INC.1,829,670$16.5M
SLNOSOLENO THERAPEUTICS INC483,884$16.2M
ANIPANI PHARMACEUTICALS INC210,130$16.2M
COGTCogent Biosciences, Inc.394,000$15.2M
ARDXARDELYX, INC.2,435,548$14.6M
ANABANAPTYSBIO, INC254,736$14.1M
CMPXCompass Therapeutics, Inc.2,550,356$13.5M
KURAKura Oncology, Inc.1,636,733$13.3M
BHVNBiohaven Ltd.1,540,445$13.0M
ZYMEZymeworks Inc.511,937$12.8M
ARVNARVINAS, INC.1,201,635$12.7M
RGNXREGENXBIO Inc.1,310,493$11.0M
ORICOric Pharmaceuticals, Inc.859,491$10.9M
CTMXCytomX Therapeutics, Inc.2,249,583$10.6M
ATAIAtai Beckley N.V.2,891,942$10.2M
HRMYHarmony Biosciences Holdings, Inc.352,637$9.9M
LGNDLigand Pharmaceuticals Incorporated47,659$9.5M
ADPTAdaptive Biotechnologies Corp639,377$8.9M
NUVBNuvation Bio Inc.2,042,312$8.8M
PCVXVaxcyte, Inc.145,371$8.4M
DFTXDefinium Therapeutics Inc.426,055$8.1M
KROSKeros Therapeutics, Inc.724,926$8.0M
ZVRAZEVRA THERAPEUTICS, INC.842,319$7.9M
NRIXNurix Therapeutics, Inc.485,212$7.5M
DMRADamora Therapeutics, Inc.282,436$7.3M
OCGNOcugen, Inc.3,773,066$6.8M
AGIOAGIOS PHARMACEUTICALS, INC.187,667$6.3M
RLAYRelay Therapeutics, Inc.619,652$6.2M
PRTAPROTHENA CORP PUBLIC LTD CO614,603$6.0M
UPBUpstream Bio, Inc.619,321$5.6M
CMPSCOMPASS Pathways plc948,554$5.2M
OLMAOlema Pharmaceuticals, Inc.312,812$4.7M
RLMDRELMADA THERAPEUTICS, INC.653,333$4.5M
VRDNViridian Therapeutics, Inc.\DE231,270$4.5M
OCULOCULAR THERAPEUTIX, INC531,816$4.5M
INCYIncyte Corp.45,431$4.3M
MAZEMaze Therapeutics, Inc.134,950$4.0M
LRMRLarimar Therapeutics, Inc.847,644$3.8M
KALVKalVista Pharmaceuticals, Inc.180,314$3.6M
IMTXImmatics N.V.366,772$3.6M
GPCRStructure Therapeutics Inc.73,599$3.5M
IVVDInvivyd, Inc.2,687,195$3.5M
IONSIONIS PHARMACEUTICALS INC42,856$3.2M
ZURAZura Bio Ltd450,311$2.7M
AVTXAvalo Therapeutics, Inc.174,506$2.6M
DNTHDianthus Therapeutics, Inc. /DE/30,354$2.5M
FBRXForte Biosciences, Inc.85,969$2.2M
SIGASIGA TECHNOLOGIES INC415,104$2.2M
GERNGERON CORP1,445,859$2.2M
PHVSPharvaris N.V.71,210$2.0M
CCCCC4 Therapeutics, Inc.752,114$2.0M
ASMBASSEMBLY BIOSCIENCES, INC.69,256$1.9M
TEVATeva Pharmaceutical Industries Limited59,306$1.8M
GRFSGrifols S.A.220,377$1.8M
IMMXImmix Biopharma, Inc.187,675$1.7M
SIONSionna Therapeutics, Inc.42,242$1.7M
ZNTLZentalis Pharmaceuticals, Inc.637,116$1.5M
BCYCBICYCLE THERAPEUTICS PLC308,617$1.4M
CGEMCullinan Therapeutics, Inc.90,316$1.3M
LYELLyell Immunopharma, Inc.55,110$1.1M
TRDAEntrada Therapeutics, Inc.87,453$1.1M
SGMTSagimet Biosciences Inc.182,738$955K
XFORX4 Pharmaceuticals, Inc218,954$904K
RCUSArcus Biosciences, Inc.38,556$833K
MLTXMoonLake Immunotherapeutics42,917$800K
CLYMClimb Bio, Inc.104,217$714K
BBOTBridgeBio Oncology Therapeutics, Inc.71,925$644K
ESPREsperion Therapeutics, Inc.208,161$570K
SLNSilence Therapeutics Plc104,555$551K
SVRASavara Inc87,575$478K
OPKOPKO HEALTH, INC.404,358$461K
TENXTENAX THERAPEUTICS, INC.28,285$452K
SRZNSurrozen Inc.14,516$423K
LCTXLineage Cell Therapeutics, Inc.259,561$410K
DSGNDesign Therapeutics, Inc.34,183$364K
GALTGALECTIN THERAPEUTICS INC126,439$353K
JBIOJade Biosciences, Inc.24,792$348K
SANASana Biotechnology, Inc.100,082$288K
EXELEXELIXIS, INC.6,623$284K
ARMPArmata Pharmaceuticals, Inc.26,628$273K
ALXOALX ONCOLOGY HOLDINGS INC107,647$216K
OVIDOvid Therapeutics Inc.94,301$209K
FENCFENNEC PHARMACEUTICALS INC.29,378$181K
CRBPCorbus Pharmaceuticals Holdings, Inc.18,476$173K
WHWKWhitehawk Therapeutics, Inc.48,307$167K
ALDXAldeyra Therapeutics, Inc.87,078$147K
ELTXElicio Therapeutics, Inc.12,482$133K
IMUXIMMUNIC, INC.111,460$124K
CAMPCamp4 Therapeutics Corp24,803$109K
SABSSAB BIOTHERAPEUTICS, INC.24,098$92K
ANTXAN2 Therapeutics, Inc.24,168$83K
ORMPORAMED PHARMACEUTICALS INC.23,504$80K
KZIAKAZIA THERAPEUTICS LTD10,608$79K
DMACDiaMedica Therapeutics Inc.10,881$74K
VYGRVoyager Therapeutics, Inc.17,505$68K
CATXPerspective Therapeutics, Inc.15,608$65K
KLRSKalaris Therapeutics, Inc.11,103$64K
PRLDPrelude Therapeutics Inc16,417$56K
AGENAGENUS INC10,474$35K
CNTXContext Therapeutics Inc.11,398$30K
BDTXBlack Diamond Therapeutics, Inc.13,407$29K
INOINOVIO PHARMACEUTICALS, INC.14,651$25K
HRTXHERON THERAPEUTICS, INC. /DE/30,355$24K
ATNMActinium Pharmaceuticals, Inc.18,048$18K
ELUTELUTIA INC.17,076$18K
PLRXPLIANT THERAPEUTICS, INC.10,966$14K

13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.